Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03843021 · ClinicalTrials.gov registry record
Ventricular Assist Device (VAD) Infection Prevention Survey
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 208
- Enrollment target
NCT03843021: Completed study, sponsored by University of Michigan.
NCT03843021 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 208 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03843021 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
Annually, more than 250,000 patients in the U.S. with end-stage heart failure stand to benefit from ventricular assist device (VAD) therapy. 60% of patients develop a healthcare-associated infection (HAI) within 90-days of implantation. The investigators long term goal is to develop and subsequently promote wide-scale adoption of evidence-based HAI prevention practices following durable VAD implantation. This will be done by addressing the following aims: Aim 1. Identify determinants of center-level variability in HAI rates. Aim 2. Develop a comprehensive understanding of barriers and facilitators for achieving low center HAI rates. Aim 3. Develop, iteratively enhance, and disseminate a best practices toolkit for preventing HAIs that accommodates various center contexts. The investigators will use a focused survey of U.S. VAD centers to identify determinants of center variation in 90-day HAI rates: * Process Factors (e.g., intranasal mupirocin), * Provider Factors (e.g., surgeon technique), * Device Factors (e.g., centrifugal vs. axial), * Center Factors (e.g., provider communication). Understanding the barriers and facilitators within individual centers for maximizing adoption of prevention measures would serve as the foundation for targeted improvement strategies. Without this knowledge, evidence-based, action-oriented recommendations will have limited local adoption and ultimately effectiveness in preventing HAIs after VAD implantation.
Primary Outcome
We will use a survey to identify a center's use of practices that may explain their center's HAI rate
Interventions
- OTHER VAD Infection Prevention Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2019-05-29 |
| Est. Completion | 2022-12-23 |
What the finished NCT03843021 record still lists
NCT03843021 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which VAD Infection Prevention Survey is the first listed.
NCT03843021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03843021 about?
NCT03843021 is a clinical study titled "Ventricular Assist Device (VAD) Infection Prevention Survey". Annually, more than 250,000 patients in the U.S. with end-stage heart failure stand to benefit from ventricular assist device (VAD) therapy. 60% of patients develop a healthcare-associated infection (HAI) within 90-days of implantation. The investigators long term goal is to develop and subsequently...
What is the current status of trial NCT03843021?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2019-05-29. Estimated completion is 2022-12-23.
What interventions are being tested in trial NCT03843021?
The interventions under investigation include: VAD Infection Prevention Survey (OTHER).
Who is sponsoring clinical trial NCT03843021?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI